Lb Pharmaceuticals Inc (LBRX) Annual Balance Sheets

Annual · GAAP · USD millions
Access LBRX quarterly Balance Sheets →
A period-by-period view of the balance sheet from Lb Pharmaceuticals Inc to helps clarify how Dec 31 2024's financial structure has changed over time.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2024)
Assets
Cash & cash equivalent25.45
Marketable Securities, Current SH5.02
Cash & Short-term Investments30.00
Prepaid Expense And Other Assets Current0.94
Total Current Assets28.88
Equipment/Property/Plant Net1.96
Tax Assets, Noncurrent0.55
Total Assets33.53
Liabilities
Accounts Payable, Current AC2.32
Accrued Liabilities, Current AC5.30
Financial Instruments2.50
Total Current Liabilities8.11
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.80
Accrued Income Taxes, Noncurrent0.55
Total Liabilities13.83
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock9.66
Retained Earnings / Accumulated Deficit-104.32
Accumulated Other Comprehensive Income0.11
Other Equity0.11
Common Stockholder's Equity-329.30
Non-controlling interests & other234.74
Total Stockholder's Equity-94.55
Liabilities & Stockholder's Equity33.53
4 historic quarters locked

Sign in to unlock the full Lb Pharmaceuticals Inc balance sheet history.

About Lb Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-126368

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License